Salicylamide

Salicylamide is an inhibitor of microsomal UDP-glucuronosyltransferase. Salicylamide is an analgesic and anti-pyretic agent.

Product Specifications

CAS Number

[65-45-2]

Product Name Alternative

2-Hydroxybenzamide

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

UGT

Type

Natural Products

Related Pathways

Metabolic Enzyme/Protease

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/Salicylamide.html

Purity

99.95

Solubility

DMSO : 100 mg/mL (ultrasonic) |H2O : 0.1 mg/mL (ultrasonic)

Smiles

O=C(N)C1=CC=CC=C1O

Molecular Formula

C7H7NO2

Molecular Weight

137.14

Precautions

H302, H315, H319, H335

References & Citations

[1]Kushkevych I, et al. Activity of selected salicylamides against intestinal sulfate-reducing bacteria. Neuro Endocrinol Lett. 2015;36 Suppl 1:106-13.|[2]Halstead PK, et al. Effect of salicylamide on skeletal glycosaminoglycan sulfation and calcification in fetal rat limbs. Drug Nutr Interact. 1981;1 (1) :75-86.|[3]Knight E, et al. Effect of salicylamide on the placental transfer and fetal tissue distribution of sodium-35S-sulfate in the rat. J Nutr. 1978 Feb;108 (2) :216-25.